Multiplication of the tinniwell sales
Egnach, June 3, 2024 - After the countries Switzerland, Austria, and Germany have been tapped, the tinniwell will be introduced in the markets of Great Britain and France. With an average of about 15% of the population affected by tinnitus, there is a market potential of around 20 million patients. This means more than doubling the sales of tinniwell in Europe.
++ About Resaphene Suisse AG
Resaphene Suisse AG, based in Egnach, Switzerland, is a medical technology company founded in 2015 that has been selling a tinnitus therapy device under the name tinniwell since 2016.
++ Contact for inquiries:
Resaphene Suisse AG
Ms. Anke Rauterkus (Chief Executive Officer)
Bahnhofplatz 5
9322 Egnach
Switzerland
T. +41 714500668